National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 6) (PB 75 of 2020) (Cth)

Case

PB 75 of 2020

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 6)

National Health Act 1953

___________________________________________________________________________

I, NIKOLAI TSYGANOV, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated    30  July 2020

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

  1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 6).

(2)This Instrument may also be cited as PB 75 of 2020.

  1. Commencement

This Instrument commences on 1 August 2020.

  1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

  1. Schedule 1, omit entry for Hydromorphone

  1. Schedule 1, entry for Levodopa with carbidopa

Omit:

Levodopa with carbidopa Tablet 100 mg‑25 mg (as monohydrate) Oral Sinemet 100/25 100 19.33 23.34

Substitute:

Levodopa with carbidopa Tablet 100 mg‑25 mg (as monohydrate) Oral Sinemet 100/25 100 19.33 24.67
Tablet 250 mg-25 mg (as monohydrate) Oral Sinemet 100 23.84 29.19
  1. Schedule 1, entry for Methylphenidate

omit from the column headed “Claimed Price”:   10.00      substitute:                12.00

  1. Schedule 1, entry for Quetiapine

Omit:

Quetiapine Tablet (modified release) 50 mg (as fumarate) Oral Seroquel XR 60 10.86 15.66
Tablet (modified release) 150 mg (as fumarate) Oral Seroquel XR 60 15.36 25.36
Tablet (modified release) 200 mg (as fumarate) Oral Seroquel XR 60 31.60 33.60
Tablet (modified release) 300 mg (as fumarate) Oral Seroquel XR 60 40.59 42.59
Tablet (modified release) 400 mg (as fumarate) Oral Seroquel XR 60 55.33 57.33

Substitute:

Quetiapine Tablet 25 mg (as fumarate) Oral Seroquel 60 5.43 10.08
Tablet (modified release) 50 mg (as fumarate) Oral Seroquel XR 60 10.86 15.66
Tablet 100 mg (as fumarate) Oral Seroquel 90 15.36 20.01
Tablet (modified release) 150 mg (as fumarate) Oral Seroquel XR 60 15.36 25.36
Tablet (modified release) 200 mg (as fumarate) Oral Seroquel XR 60 31.60 33.60
Tablet 200 mg (as fumarate) Oral Seroquel 60 20.93 25.58
Tablet (modified release) 300 mg (as fumarate) Oral Seroquel XR 60 40.59 42.59
Tablet 300 mg (as fumarate) Oral Seroquel 60 30.72 35.37
Tablet (modified release) 400 mg (as fumarate) Oral Seroquel XR 60 55.33 57.33
  1. Schedule 1, entry for Rosuvastatin in the form of Tablet 5 mg (as calcium)

omit from the column headed “Claimed Price”:   3.85        substitute:                4.45

  1. Schedule 1, entry for Rosuvastatin in the form of Tablet 20 mg (as calcium)

omit from the column headed “Claimed Price”:   6.51        substitute:                7.11

  1. Schedule 1, entry for Rosuvastatin in the form of Tablet 40 mg (as calcium)

omit from the column headed “Claimed Price”:   9.33        substitute:                10.20

  1. Schedule 1, entry for Salbutamol

Omit:

Salbutamol Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 Inhalation Ventolin Nebules 20 2..48 4.04
Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 Inhalation Asmol 2.5 uni‑dose 1 3.72 3.95
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 Inhalation Ventollin Nebules 1 2.61 4.16
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 Inhalation Asmol 5 uni-dose 1 3.92 4.15
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation) Inhalation by mouth Ventolin CFC-free 1 3.90 5.60

Substitute:

Salbutamol Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 Inhalation Ventolin Nebules 20 2..48 4.04
Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 Inhalation Asmol 2.5 uni‑dose 1 3.72 3.95
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 Inhalation Ventollin Nebules 1 2.61 4.16
Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 Inhalation Asmol 5 uni-dose 1 3.92 4.15
Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation) Inhalation by mouth Ventolin CFC-free 1 3.90 5.60
Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) Inhalation by mouth Ventolin 1 4.49 6.82
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0